Téthys Invest

Françoise Bettencourt Meyers holds the chair and ultimate investment authority. Her husband Jean-Pierre Meyers runs Téthys SAS, the parent holding company through which the family's L'Oréal stake and private assets are structured. Their sons, Jean-Victor and Nicolas, sit on the supervisory board, indicating a formalized next-generation governance role in both capital allocation and oversight.

The family office leans on a network of institutional co-investors — KKR, CPP Investments, and GIC have all appeared alongside Téthys in named transactions — suggesting a co-underwriting model rather than purely proprietary origination. Its long-duration capital base and willingness to write growth-scale equity checks also attract direct approaches from entrepreneurs and sponsors across Europe.

Téthys Invest is a single-family office that deploys exclusively Meyers family capital. It does not manage third-party funds. However, it frequently partners with institutional co-investors such as KKR and CPP Investments on specific direct deals, blending internal capital with external equity in a club format.

The firm uses three primary structures: direct equity investments, co-investments alongside private equity sponsors, and limited partner commitments to external funds. Its direct activity targets growth-stage and control-oriented positions in Europe while fund commitments, such as Lauxera Growth I, provide exposure to specialized strategies like healthtech venture capital.

Publicly available information does not indicate formally excluded sectors. The portfolio is concentrated on healthcare, education, legal services, and enterprise technology — all sectors with recurring-revenue business models and long-duration value creation profiles. No fossil fuel, defense, or industrial commodity positions have been confirmed.

Philanthropy is institutionally separated from the investment office through the Fondation Bettencourt Schueller, which focuses on life sciences and arts, and the Fondation Pour l'Audition, dedicated to hearing health. These foundations are independently governed and fund research, cultural preservation, and public-health initiatives rather than making mission-related investments alongside Téthys Invest.

Téthys is an active, visible co-investor. It has partnered with KKR on April Group and Galileo Global Education, with CPP Investments on Galileo, and with GIC on Septeo Group. This pattern suggests the family office seeks to write substantial checks — often in the hundreds of millions — by syndicating with institutional GPs rather than leading solo.